Orchid Pharma Limited (ORCHPHARMA.NS)
INR 1794.0
(0.9%)
INR 1794.0
(0.9%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.64 Billion INR | 15.51% |
| 2022 | 2.28 Billion INR | 32.48% |
| 2021 | 1.72 Billion INR | 12.93% |
| 2020 | 1.52 Billion INR | -1.81% |
| 2019 | 1.55 Billion INR | -8.28% |
| 2018 | 1.69 Billion INR | -12.37% |
| 2017 | 1.93 Billion INR | -8.29% |
| 2016 | 2.11 Billion INR | -12.65% |
| 2015 | 2.41 Billion INR | -4.0% |
| 2014 | 2.51 Billion INR | -50.24% |
| 2013 | 5.06 Billion INR | 0.0% |
| 2011 | 6.68 Billion INR | 8.27% |
| 2010 | 6.17 Billion INR | 46.14% |
| 2009 | 4.22 Billion INR | -44.99% |
| 2008 | 7.68 Billion INR | 18.35% |
| 2007 | 6.49 Billion INR | 6.14% |
| 2006 | 6.11 Billion INR | 36.48% |
| 2005 | 4.48 Billion INR | 11.88% |
| 2004 | 4 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 2.64 Billion INR | 15.51% |
| 2023 Q2 | 2.22 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 2.64 Billion INR | 0.0% |
| 2022 Q2 | 2.36 Billion INR | 0.0% |
| 2022 Q4 | 2.28 Billion INR | 0.0% |
| 2022 FY | 2.28 Billion INR | 32.48% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.72 Billion INR | 12.93% |
| 2021 Q4 | 1.72 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.86 Billion INR | 0.0% |
| 2020 Q2 | 2.05 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 1.52 Billion INR | 0.0% |
| 2020 FY | 1.52 Billion INR | -1.81% |
| 2020 Q1 | - INR | -100.0% |
| 2019 FY | 1.55 Billion INR | -8.28% |
| 2019 Q4 | 1.55 Billion INR | 0.0% |
| 2019 Q1 | - INR | 0.0% |
| 2018 FY | 1.69 Billion INR | -12.37% |
| 2018 Q2 | 1.73 Billion INR | 0.0% |
| 2017 FY | 1.93 Billion INR | -8.29% |
| 2016 FY | 2.11 Billion INR | -12.65% |
| 2015 FY | 2.41 Billion INR | -4.0% |
| 2014 FY | 2.51 Billion INR | -50.24% |
| 2013 FY | 5.06 Billion INR | 0.0% |
| 2013 Q2 | 5.06 Billion INR | 0.0% |
| 2011 FY | 6.68 Billion INR | 8.27% |
| 2011 Q4 | 6.68 Billion INR | 0.0% |
| 2010 FY | 6.17 Billion INR | 46.14% |
| 2009 FY | 4.22 Billion INR | -44.99% |
| 2008 FY | 7.68 Billion INR | 18.35% |
| 2007 FY | 6.49 Billion INR | 6.14% |
| 2006 FY | 6.11 Billion INR | 36.48% |
| 2005 FY | 4.48 Billion INR | 11.88% |
| 2004 FY | 4 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sigachi Industries Limited | 707.2 Million INR | -273.619% |
| Ind-Swift Limited | 640.91 Million INR | -312.264% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -83.442% |
| Sakar Healthcare Limited | 277.32 Million INR | -852.774% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 97.306% |
| Innova Captab Limited | 1.44 Billion INR | -83.47% |
| Divi's Laboratories Limited | 31.84 Billion INR | 91.701% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -15.949% |
| Morepen Laboratories Limited | 2.48 Billion INR | -6.288% |
| Mankind Pharma Limited | 15.53 Billion INR | 82.991% |
| Sequent Scientific Limited | 3.46 Billion INR | 23.685% |
| Wanbury Limited | 360.23 Million INR | -633.489% |
| Laurus Labs Limited | 18.45 Billion INR | 85.682% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 62.741% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 60.362% |
| Alembic Limited | 113.4 Million INR | -2230.036% |
| Hikal Limited | 3.03 Billion INR | 13.003% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 83.923% |
| Neuland Laboratories Limited | 3.5 Billion INR | 24.598% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 47.419% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 89.486% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 37.806% |
| Themis Medicare Limited | 705.74 Million INR | -274.394% |
| RPG Life Sciences Limited | 1.01 Billion INR | -161.61% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 92.323% |
| Lupin Limited | 49.53 Billion INR | 94.666% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -814.128% |
| Wockhardt Limited | 6.4 Billion INR | 58.715% |
| Vaishali Pharma Limited | 3.79 Million INR | -69488.122% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 58.898% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -1661.86% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 79.511% |
| FDC Limited | 3.88 Billion INR | 32.056% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 95.842% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -6525.529% |
| Eris Lifesciences Limited | 1.89 Billion INR | -39.779% |
| Venus Remedies Limited | 1.21 Billion INR | -117.13% |
| ZIM Laboratories Limited | 812.62 Million INR | -225.15% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -123.075% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -6225.739% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 27.218% |
| Shilpa Medicare Limited | 3.44 Billion INR | 23.397% |
| Albert David Limited | 436.12 Million INR | -505.855% |
| Ajanta Pharma Limited | 8.28 Billion INR | 68.103% |
| Hester Biosciences Limited | 755.81 Million INR | -249.593% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -14.287% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 26.543% |
| Gufic Biosciences Limited | 2 Billion INR | -31.795% |
| Windlas Biotech Limited | 621.89 Million INR | -324.876% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -142.165% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -661.991% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -113.706% |
| Granules India Limited | 13 Billion INR | 79.683% |
| Aarti Drugs Limited | 4.85 Billion INR | 45.62% |
| Bal Pharma Limited | 878.11 Million INR | -200.902% |
| Alkem Laboratories Limited | 26.61 Billion INR | 90.071% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 97.322% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -242.403% |
| Medicamen Biotech Limited | 593.75 Million INR | -345.011% |
| Unichem Laboratories Limited | 7.04 Billion INR | 62.504% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -791.397% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -10263.027% |
| Valiant Laboratories Limited | 100.15 Million INR | -2538.198% |
| Medico Remedies Limited | 163.37 Million INR | -1517.328% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -2426.618% |
| Ipca Laboratories Limited | 24.71 Billion INR | 89.308% |
| Brooks Laboratories Limited | 96.1 Million INR | -2649.262% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -1153.355% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 88.406% |
| NATCO Pharma Limited | 7 Billion INR | 62.28% |
| Suven Life Sciences Limited | 7.08 Million INR | -37193.733% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -2597.175% |
| Strides Pharma Science Limited | 11.26 Billion INR | 76.539% |
| Indoco Remedies Limited | 3.53 Billion INR | 25.161% |
| Alpa Laboratories Limited | 136.65 Million INR | -1833.555% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1287.494% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -17762.77% |